Grace Therapeutics, Inc. - CL A (GRCE)

Historical Portfolio Holders for Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / CL A
Shares, excl. options Q3 2024
960K
Holdings value Q3 2024
$2.88M
Value change Q3 2024
+$2.88M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
1
Number of buys Q3 2024
1
Number of sells Q3 2024
0
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 960K $2.88M +$2.88M $3.00 1